查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1595321

製药服务外包市场：按服务、按应用程式划分 - 2025-2030 年全球预测

Pharmaceutical Services Outsourcing Market by Service (Auditing & Assessment, Consulting, Product Design & Development), End-Use (Biotech, Pharma) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 194 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年医药服务外包市场规模为777.4亿美元，预计2024年将达到832.3亿美元，复合年增长率为7.54%，预计到2030年将达到1293.4亿美元。

医药服务外包业务领域包括製剂、临床试验管理、监理咨询等多种服务。该服务的定义是简化业务的能力，使製药公司能够专注于其核心能力，同时利用外部专业知识来提高效率和成本效益。这种需求是由药物开发日益复杂以及敏捷性和上市速度日益增加的竞争压力所推动的。外包应用于药物开发的各个阶段，包括研发、临床试验和製造，最终用途范围从生技公司到大型製药企业。这个市场的关键成长因素包括药物开发技术创新的不断步伐、需要多样化治疗解决方案的慢性疾病数量的增加以及需要本地化专业知识的临床试验的全球化。近年来，随着专业外包公司提供扩充性和先进技术力，个人化医疗和生技药品领域的机会激增。为了抓住这些机会，公司应该投资与具有利基专业知识和适应性的公司建立策略伙伴关係。另一方面，应对不断变化的监管环境、智慧财产权侵权风险和品管等挑战仍然是困难的障碍。此外，COVID-19 大流行凸显了物流和供应链的脆弱性，持续影响市场流动性。创新研究领域包括使用数位健康平台和人工智慧进行药物发现分析，预计将提高效率和预测准确性。追求永续和环保的製造流程也提供了通往市场领导地位的先进道路。市场本质上是动态的，受到快速的技术进步和不断变化的监管要求的推动，需要市场参与企业做出敏捷的反应和前瞻性的策略。平衡技术创新与强有力的安全和合规措施对于驾驭这个不断发展的生态系统至关重要。

主要市场统计
基准年[2023] 777.4亿美元
预测年份 [2024] 832.3亿美元
预测年份 [2030] 1293.4亿美元
复合年增长率（%） 7.54%

市场动态：快速发展的医药服务外包市场的关键市场洞察

供需的动态交互作用正在改变医药服务外包市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 研发活动的医药支出增加
    • 生产和研究设施运作和管理中节省成本和时间所产生的潜在需求
    • 小型製药和生物技术公司的需求不断增长
  • 市场限制因素
    • 市场竞争加剧导致利润率下降
  • 市场机会
    • 机器学习和人工智慧的兴起以及药物开发的自动化
    • 大规模投资再生医学等新治疗方法
  • 市场挑战
    • 药品品质缺乏一致性

波特五力：驾驭医药服务外包市场的策略工具

波特的五力框架是理解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解医药服务外包市场的外部影响

外部宏观环境因素在塑造医药服务外包市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解医药服务外包市场竞争状况

医药服务外包市场的详细市场占有率分析可以对供应商绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 医药服务外包市场供应商定位矩阵绩效评估

FPNV 定位矩阵是评估製药服务外包市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析与建议绘製医药服务外包市场的成功之路

对于旨在加强在全球市场的影响力的公司来说，对製药服务外包市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 增加研发活动的医药支出
      • 生产和研究设施运作和管理中节省成本和时间所产生的潜在需求
      • 中小型製药公司和生技公司的需求增加
    • 抑制因素
      • 市场竞争激烈导致利润率下降
    • 机会
      • 机器学习和人工智慧在药物开发的介绍和自动化进展
      • 对再生医学等新治疗方法和治疗方法的大量投资
    • 任务
      • 药品品质缺乏一致性
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章 医药服务外包市场：依服务分类

  • 审核与评估
  • 咨询
  • 产品设计与开发
  • 产品维护
  • 产品测试和检验
  • 监管业务
  • 培训和教育

第七章 医药服务外包市场：依最终用途分类

  • 生物技术
  • 製药

第八章美洲医药服务外包市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第九章亚太医药服务外包市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十章 欧洲/中东/非洲医药服务外包市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十一章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • Cambrex Corporation
  • CareCloud, Inc.
  • Cerner Corporation
  • Charles River Laboratories International, Inc.
  • Concept Heidelberg GmbH
  • Eurofins Scientific SE
  • ICON PLC
  • Inspired Pharma Training Ltd.
  • IQVIA Inc.
  • Lachman Consultant Services, Inc.
  • NextGen Healthcare, Inc.
  • Parexel International Corporation
  • Reading Scientific Services Ltd.
  • SGS SA
  • The Quantic Group
Product Code: MRR-CA17E905E8BD

The Pharmaceutical Services Outsourcing Market was valued at USD 77.74 billion in 2023, expected to reach USD 83.23 billion in 2024, and is projected to grow at a CAGR of 7.54%, to USD 129.34 billion by 2030.

The scope of pharmaceutical services outsourcing encompasses a variety of offerings that include drug formulation, clinical trial management, and regulatory consulting, among others. Defined by its capacity to streamline operations, it allows pharmaceutical companies to focus on core functions while leveraging expert external capabilities to enhance efficiency and cost-effectiveness. This necessity stems from the growing complexity of drug development and competitive pressures that demand agility and speed-to-market. Outsourcing is applied across various stages of drug development, including R&D, clinical trials, and manufacturing, with end-use sectors ranging from biotechnology firms to large pharmaceutical companies. Key growth factors fueling this market include the relentless pace of innovation in drug development, increasing prevalence of chronic diseases requiring diverse therapeutic solutions, and the globalization of clinical trials necessitating localized expertise. Lately, there are burgeoning opportunities in personalized medicine and biologics, where specialized outsourcing firms offer scalability and advanced technological capabilities. To capture these opportunities, companies should invest in strategic partnerships with firms possessing niche expertise and adaptive capacity. On the flip side, challenges such as compliance with ever-evolving regulatory landscapes, risks of intellectual property breaches, and quality control remain daunting hurdles. Furthermore, the COVID-19 pandemic underscored logistical and supply chain vulnerabilities that continue to impact market fluidity. Innovatively, the best areas for research lie in digital health platforms and AI-enhanced analytics for drug discovery, which promise to propel efficiency and predictive accuracy. Delving into sustainable and eco-friendly manufacturing processes also offers a progressive pathway for market leadership. The market is inherently dynamic, driven by rapid technological advancements and shifting regulatory demands, necessitating agile responses and forward-thinking strategies from market participants. Balancing innovation with robust safety and compliance measures will be essential in navigating this evolving ecosystem.

KEY MARKET STATISTICS
Base Year [2023] USD 77.74 billion
Estimated Year [2024] USD 83.23 billion
Forecast Year [2030] USD 129.34 billion
CAGR (%) 7.54%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Pharmaceutical Services Outsourcing Market

The Pharmaceutical Services Outsourcing Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing pharmaceutical expenditure on research and development activities
    • Potential need attributed to cost and time saving in operations and management of a production & research facility
    • Growing demand from small pharmaceuticals and biotechnology companies
  • Market Restraints
    • Reduced profit margins owing to robust competition in the market
  • Market Opportunities
    • Emerging adoption of machine learning and artificial intelligence coupled with automation in drug development
    • Extensive investment in novel and therapeutic therapies such as regenerative medicine
  • Market Challenges
    • Lack of consistency in the pharmaceutical product quality

Porter's Five Forces: A Strategic Tool for Navigating the Pharmaceutical Services Outsourcing Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Pharmaceutical Services Outsourcing Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Pharmaceutical Services Outsourcing Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Pharmaceutical Services Outsourcing Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Pharmaceutical Services Outsourcing Market

A detailed market share analysis in the Pharmaceutical Services Outsourcing Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Pharmaceutical Services Outsourcing Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Pharmaceutical Services Outsourcing Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Pharmaceutical Services Outsourcing Market

A strategic analysis of the Pharmaceutical Services Outsourcing Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Pharmaceutical Services Outsourcing Market, highlighting leading vendors and their innovative profiles. These include Cambrex Corporation, CareCloud, Inc., Cerner Corporation, Charles River Laboratories International, Inc., Concept Heidelberg GmbH, Eurofins Scientific SE, ICON PLC, Inspired Pharma Training Ltd., IQVIA Inc., Lachman Consultant Services, Inc., NextGen Healthcare, Inc., Parexel International Corporation, Reading Scientific Services Ltd., SGS SA, and The Quantic Group.

Market Segmentation & Coverage

This research report categorizes the Pharmaceutical Services Outsourcing Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Service, market is studied across Auditing & Assessment, Consulting, Product Design & Development, Product Maintenance, Product Testing & Validation, Regulatory Affairs, and Training & Education.
  • Based on End-Use, market is studied across Biotech and Pharma.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing pharmaceutical expenditure on research and development activities
      • 5.1.1.2. Potential need attributed to cost and time saving in operations and management of a production & research facility
      • 5.1.1.3. Growing demand from small pharmaceuticals and biotechnology companies
    • 5.1.2. Restraints
      • 5.1.2.1. Reduced profit margins owing to robust competition in the market
    • 5.1.3. Opportunities
      • 5.1.3.1. Emerging adoption of machine learning and artificial intelligence coupled with automation in drug development
      • 5.1.3.2. Extensive investment in novel and therapeutic therapies such as regenerative medicine
    • 5.1.4. Challenges
      • 5.1.4.1. Lack of consistency in the pharmaceutical product quality
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Pharmaceutical Services Outsourcing Market, by Service

  • 6.1. Introduction
  • 6.2. Auditing & Assessment
  • 6.3. Consulting
  • 6.4. Product Design & Development
  • 6.5. Product Maintenance
  • 6.6. Product Testing & Validation
  • 6.7. Regulatory Affairs
  • 6.8. Training & Education

7. Pharmaceutical Services Outsourcing Market, by End-Use

  • 7.1. Introduction
  • 7.2. Biotech
  • 7.3. Pharma

8. Americas Pharmaceutical Services Outsourcing Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Pharmaceutical Services Outsourcing Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Pharmaceutical Services Outsourcing Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Cambrex Corporation
  • 2. CareCloud, Inc.
  • 3. Cerner Corporation
  • 4. Charles River Laboratories International, Inc.
  • 5. Concept Heidelberg GmbH
  • 6. Eurofins Scientific SE
  • 7. ICON PLC
  • 8. Inspired Pharma Training Ltd.
  • 9. IQVIA Inc.
  • 10. Lachman Consultant Services, Inc.
  • 11. NextGen Healthcare, Inc.
  • 12. Parexel International Corporation
  • 13. Reading Scientific Services Ltd.
  • 14. SGS SA
  • 15. The Quantic Group

LIST OF FIGURES

  • FIGURE 1. PHARMACEUTICAL SERVICES OUTSOURCING MARKET RESEARCH PROCESS
  • FIGURE 2. PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. PHARMACEUTICAL SERVICES OUTSOURCING MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. PHARMACEUTICAL SERVICES OUTSOURCING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. PHARMACEUTICAL SERVICES OUTSOURCING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. PHARMACEUTICAL SERVICES OUTSOURCING MARKET DYNAMICS
  • TABLE 7. GLOBAL PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY AUDITING & ASSESSMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY CONSULTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY PRODUCT DESIGN & DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY PRODUCT MAINTENANCE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY PRODUCT TESTING & VALIDATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY REGULATORY AFFAIRS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY TRAINING & EDUCATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY BIOTECH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY PHARMA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 21. ARGENTINA PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 22. ARGENTINA PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 23. BRAZIL PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 24. BRAZIL PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 25. CANADA PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 26. CANADA PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 27. MEXICO PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 28. MEXICO PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 29. UNITED STATES PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 30. UNITED STATES PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 31. UNITED STATES PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 32. ASIA-PACIFIC PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 33. ASIA-PACIFIC PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 34. ASIA-PACIFIC PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 35. AUSTRALIA PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 36. AUSTRALIA PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 37. CHINA PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 38. CHINA PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 39. INDIA PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 40. INDIA PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 41. INDONESIA PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 42. INDONESIA PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 43. JAPAN PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 44. JAPAN PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 45. MALAYSIA PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 46. MALAYSIA PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 47. PHILIPPINES PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 48. PHILIPPINES PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 49. SINGAPORE PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 50. SINGAPORE PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 51. SOUTH KOREA PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 52. SOUTH KOREA PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 53. TAIWAN PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 54. TAIWAN PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 55. THAILAND PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 56. THAILAND PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 57. VIETNAM PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 58. VIETNAM PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 59. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 60. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 61. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 62. DENMARK PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 63. DENMARK PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 64. EGYPT PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 65. EGYPT PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 66. FINLAND PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 67. FINLAND PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 68. FRANCE PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 69. FRANCE PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 70. GERMANY PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 71. GERMANY PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 72. ISRAEL PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 73. ISRAEL PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 74. ITALY PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 75. ITALY PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 76. NETHERLANDS PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 77. NETHERLANDS PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 78. NIGERIA PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 79. NIGERIA PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 80. NORWAY PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 81. NORWAY PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 82. POLAND PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 83. POLAND PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 84. QATAR PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 85. QATAR PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 86. RUSSIA PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 87. RUSSIA PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 88. SAUDI ARABIA PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 89. SAUDI ARABIA PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 90. SOUTH AFRICA PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 91. SOUTH AFRICA PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 92. SPAIN PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 93. SPAIN PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 94. SWEDEN PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 95. SWEDEN PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 96. SWITZERLAND PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 97. SWITZERLAND PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 98. TURKEY PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 99. TURKEY PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 100. UNITED ARAB EMIRATES PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 101. UNITED ARAB EMIRATES PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 102. UNITED KINGDOM PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 103. UNITED KINGDOM PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 104. PHARMACEUTICAL SERVICES OUTSOURCING MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 105. PHARMACEUTICAL SERVICES OUTSOURCING MARKET, FPNV POSITIONING MATRIX, 2023